A phase II trial of oblimersen sodium (G3139) plus rituximab for treatment of patients with recurrent B-cell non-Hodgkin's lymphoma Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pro, B
  • Leber, Brian
  • Smith, M
  • Younes, A
  • Fayad, L
  • Hagemeister, F
  • McLaughlin, P
  • Rodriguez, M
  • Kwak, LW
  • Caddick, Y
  • Zwiebel, J

publication date

  • June 1, 2005